Re: Ask Chris a question in regards to my concern over the Hepa Board departure..
|
2
|
Resverlogix Corp.
|
Feb 29, 2024 02:30PM
|
Re: Possibility?
|
2
|
Resverlogix Corp.
|
May 08, 2024 08:57AM
|
Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024
|
2
|
Zenith Epigenetics
|
Oct 15, 2024 01:09PM
|
ok ok how's this Tada..
|
2
|
Resverlogix Corp.
|
Sep 29, 2021 01:51PM
|
Re: what if Don
|
2
|
Resverlogix Corp.
|
Oct 12, 2021 01:25PM
|
Re: Additional Exempt Distribution
|
2
|
Zenith Epigenetics
|
Dec 06, 2023 11:43AM
|
Re: Merck’s pill
|
2
|
Resverlogix Corp.
|
Oct 07, 2021 03:06PM
|
Re: (Newsfile Corp. - July 16, 2024)
|
2
|
Resverlogix Corp.
|
Jul 16, 2024 10:56AM
|
Re: what if Don
|
2
|
Resverlogix Corp.
|
Oct 12, 2021 01:38PM
|
Re: insiders going it alone?
|
2
|
Resverlogix Corp.
|
Jan 30, 2021 12:38PM
|
Hepalink ends their trading week sitting on a new 52 week low..
|
2
|
Resverlogix Corp.
|
Nov 15, 2019 08:47AM
|
picked up several thousand shares under .89 cents this morning!!
|
2
|
Resverlogix Corp.
|
Mar 18, 2020 12:45PM
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
2
|
Resverlogix Corp.
|
Mar 03, 2021 12:42PM
|
is it a possibility we see r v x sell
|
2
|
Resverlogix Corp.
|
Mar 18, 2021 04:14PM
|
Re: The crick didn’t rise, here’s the presentation, finally!
|
2
|
Zenith Epigenetics
|
Oct 28, 2023 01:14PM
|
Re: The fact remains
|
2
|
Resverlogix Corp.
|
Apr 15, 2024 05:02PM
|
Re: short # ?
|
2
|
Resverlogix Corp.
|
Apr 22, 2022 02:08PM
|
Based on IR’s response
|
2
|
Resverlogix Corp.
|
Feb 26, 2024 04:14PM
|
Re: Science and money
|
2
|
Resverlogix Corp.
|
Apr 20, 2021 10:41AM
|
well thats one way on how rumours can get started ....
|
2
|
Resverlogix Corp.
|
Nov 10, 2020 08:00PM
|